By Nancy Lapid March 4 (Reuters) - Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent new substance use ...

By Andrew Silver SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight ...

A scientist has explained why 'healthy people' who are taking GLP-1 drugs are actually 'part of the experiment' as the drug ...

Ozempic and other GLP-1 agonist drugs have become an enormously popular way to lose weight. And with generic, much cheaper versions of the medications on the horizon, their use could soon grow even ...

With off‑label use surging, it’s virtually impossible to know how many people are currently taking GLP‑1 drugs like Wegovy or Mounjaro, or how many will be prescribed them in the years ahead. The same ...

The UK green loans market is adapting to borrower needs and lenders should be primed to re-examine their portfolios and offer a broader suite of green products.

A dietician has explained the differences between a GLP-1 diet and one for people trying to lose weight without injections.

Every time Aditi publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Hims & Hers Health, Inc. is facing increasing regulatory pressure regarding its compounded GLP-1 offering. The GLP-1 revenue stream has been significant for HIMS, but not the only source of growth.

The growth potential in the GLP-1 market could help healthcare stocks soar in value. Competition, however, is likely to be fierce. Many drugs offer comparable weight loss. Healthcare companies have ...

Human cohort studies and meta-analyses have not shown increased incidence of common differentiated thyroid cancers with GLP-1 receptor agonist exposure. Rodent C-cell tumor signals underpin the boxed ...

Serena Williams' Super Bowl commercial, which was an ad promoting GLP-1 weight loss drugs and the telehealth company Ro, has been met with criticism online after it aired on Sunday. Williams said in ...